Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils

Davide Torti1, Livio Trusolino

  • 1Laboratory of Molecular Pharmacology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, Candiolo (Torino), Italy.

EMBO Molecular Medicine
|September 29, 2011
PubMed

Insights

Oncogene addiction, where cancers depend on a single dominant oncogene, shows promise but faces challenges. Understanding its molecular basis and overcoming drug resistance are key for effective cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The concept of oncogene addiction posits that some cancers rely on a single dominant oncogene for survival.
  • This notion has been supported by substantial evidence in both research and therapy.

Purpose of the Study:

  • To review the literature on oncogene addiction, covering biological mechanisms and clinical applications.
  • To discuss the advantages and limitations of the oncogene addiction concept.
  • To re-evaluate its role in guiding cancer research and drug development.

Main Methods:

  • Literature review of biological and clinical studies on oncogene addiction.
  • Analysis of evidence supporting and challenging the oncogene addiction model.
  • Discussion of therapeutic implications and challenges.

Main Results:

  • While oncogene addiction is a powerful concept, its underlying molecular mechanisms remain incompletely understood.
  • Clinical translation faces obstacles, primarily due to emergent resistance and escape mechanisms.
  • The concept offers valuable insights but requires further refinement.

Conclusions:

  • Oncogene addiction remains a significant principle in cancer biology and targeted therapy development.
  • Further research is needed to elucidate molecular mechanisms and overcome therapeutic resistance.
  • The concept serves as a crucial guide for post-genomic cancer research.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...